Rami Sweis

Rami Sweis

Auto-generated profile, based on publicly available information

Rami Sweis

University College London Hospitals NHS Foundation Trust, London, UK

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 March 2021 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
Mark FoxMark Fox
Mark Fox
RSRami Sweis
Rami Sweis
RYRena Yadlapati
Rena Yadlapati
JPJohn Pandolfino
John Pandolfino
AHAlbis Hani
Albis Hani
NRNathalie Rommel
Nathalie Rommel

31 January 2020 in Clinical Gastroenterology and Hepatology
Verified
Journal Article
Closed access
SHStephen Hasak
Stephen Hasak
RYRena Yadlapati
Rena Yadlapati
OAOsama Altayar
Osama Altayar
RSRami Sweis
Rami Sweis
ETEmily Tucker
Emily Tucker
CGC. Prakash Gyawali
C. Prakash Gyawali

8 April 2025 in American Journal of Gastroenterology
Verified
Journal Article
Closed access
RYRena Yadlapati
Rena Yadlapati
PWPhilip A. Weissbrod
Philip A. Weissbrod
EWErin Walsh
Erin Walsh
TCThomas L. Carroll
Thomas L. Carroll
WCWalter W. Chan
Walter W. Chan
CGC. Prakash Gyawali
C. Prakash Gyawali
INTRODUCTION: The term laryngopharyngeal reflux (LPR) is frequently applied to aerodigestive symptoms despite lack of objective reflux evidence. The aim of this initiative was to develop a modern care paradigm for LPR supported by otolaryngology and gastroenterology disciplines. METHODS: A 28-member international interdisciplinary working group developed practical statements within the following domains: definition/terminology, initial diagnostic evaluation, reflux monitoring, therapeutic trials, behavioral factors and therapy, and risk stratification. Literature reviews guided statement development and were presented at virtual/in-person meetings. Each statement underwent 2 or more rounds of voting per the RAND Appropriateness Method; statements reaching appropriateness with ≥80% agreement are included as recommendations. RESULTS: The term laryngopharyngeal symptoms (LPS) applies to aerodigestive symptoms with potential to be induced by reflux and include cough, voice change, throat clearing, excess throat phlegm, and throat pain. Laryngopharyngeal reflux disease (LPRD) refers to patients with LPS and objective evidence of reflux. Importantly, the presence of LPS does not equate to LPRD. Laryngoscopy has value in assessing for nonreflux laryngopharyngeal processes, but laryngoscopic findings alone cannot diagnose LPRD. LPS patients should be categorized as with or without concurrent esophageal reflux symptoms. While lifestyle modification and empiric trials of acid suppression ± alginates are appropriate when esophageal reflux symptoms coexist, upper endoscopy and ambulatory reflux monitoring are required for LPRD diagnosis when symptoms persist, when LPS is isolated, or when management needs to be escalated to include invasive antireflux management. The two recommended ambulatory reflux monitoring modalities, 24-hour pH-impedance and 96-hour wireless pH monitoring, are not mutually exclusive with distinct roles for the evaluation of LPS. Laryngeal hyperresponsiveness and hypervigilance commonly contribute to both LPS and LPRD presentations and are responsive to laryngeal recalibration therapy and neuromodulators. DISCUSSION: The San Diego Consensus represents the formal modern-day interdisciplinary care paradigm to evaluate and manage LPS and LPRD.

30 October 2023 in Journal of Neurogastroenterology and Motility
Verified
Journal Article
Open access
PDF file
MPMarcella Pesce
Marcella Pesce
MPMarta Pagliaro
Marta Pagliaro
GSGiovanni Sarnelli
Giovanni Sarnelli
RSRami Sweis
Rami Sweis
Marcella Pesce, Marta Pagliaro, Giovanni Sarnelli, and Rami Sweis. J Neurogastroenterol Motil 2023;29:419-27. https://doi.org/10.5056/jnm23125

25 September 2017 in Neurogastroenterology & Motility
Verified
Journal Article
Closed access
PDF file
RSR. Sweis
R. Sweis
HHHenriette Heinrich
Henriette Heinrich
MFM. Fox
M. Fox
TFthe International Working Group for GI Motility and Function
the International Working Group for GI Motility and Function

21 June 2025 in United European Gastroenterology Journal
Verified
Journal Article
Open access
AMAmir Mari
Amir Mari
FCFrancesco Calabrese
Francesco Calabrese
APAndrea Pasta
Andrea Pasta
GLGreta Lorenzon
Greta Lorenzon
BWBas Weusten
Bas Weusten
ESEdoardo Vincenzo Savarino
Edoardo Vincenzo Savarino
Dysphagia is a prevalent symptom of the upper gastrointestinal tract causing health related consequences, impacting quality of life and is associated with global economic burden. Swallowing difficulties are classified into oropharyngeal dysphagia (OD) and esophageal dysphagia. Despite its clinical importance, dysphagia is associated with several uncertainties regarding its optimal diagnostic work‐up and management, particularly, considering the progress with diagnostic modalities and technologies. A Delphi consensus was performed with experts from various disciplines who conducted a literature summary and voting process on 41 statements. Quality of evidence was evaluated using the grading of recommendations, assessment, development, and evaluation criteria. Consensus was reached for all the statements. The panel agreed with the definition and prevalence of esophageal and OD types. The role of endoscopy, high‐resolution manometry, EndoFLIP, barium swallow and other imaging tests in evaluating esophageal dysphagia has reached overall strong agreement. Videofluoroscopic swallow study, alongside fiber‐endoscopic evaluation of swallowing, as the methods of choice for the instrumental assessment of oropharyngeal dysfunction is a strong recommendation. Regarding treatment, a weak recommendation was achieved for the use of PPIs, calcium‐channel blockers, nitrates, phosphodiesterase type 5 inhibitors, antidepressants or peppermint oil for the treatment of hypercontractile esophagus. A strong recommendation exists for endoscopic and surgical treatment of achalasia, while a weak recommendation is provided for other esophageal motility disorders. Regarding OD, a weak recommendation was achieved for swallow therapy, to improve swallowing mechanics, reduce symptoms, and enhance quality of life. Swallow therapy could be more effective when using validated assessment tools, consistent treatment parameters, and considering long‐term follow‐up. A multinational group of European experts summarized the current state of consensus on the definition, diagnosis, and management of dysphagia.